{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T05:54:39Z","timestamp":1791266079116,"version":"4.1.0"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Health-related quality of life (HRQoL) is a key patient-centered outcome in HIV care, particularly in the current treatment era in which virological control is increasingly achievable but residual physical, mental, and social burden may persist. However, the clinical applicability of HIV-specific HRQoL instruments in Turkish-speaking people living with HIV (PLWH) remains insufficiently established. We aimed to characterize HRQoL in a multicenter Turkish sample of PLWH and to evaluate whether the Turkish version of the Medical Outcomes Study HIV Health Survey (MOS-HIV) provides reliable and valid scores for use in this population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this multicenter cross-sectional study, PLWH receiving care at five tertiary training and research hospitals in Istanbul completed the Turkish MOS-HIV. Cognitive debriefing was performed in 20 participants, and 244 were included in the main analysis. Domain and summary scores were calculated according to the user\u2019s manual. Internal consistency was assessed in all 244 participants and test\u2013retest reliability in a subsample of 105 after a median of 15\u202fdays. Structural validity was examined using domain-level confirmatory factor analysis and known-groups comparisons were conducted according to comorbidity status, CD4 category, history of AIDS-defining illness, and number of tablets in the treatment regimen.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Participants had a median age of 37\u202fyears and a median CD4 count of 701 cells\/mm\n                      <jats:sup>3<\/jats:sup>\n                      ; 13.5% had detectable HIV-1 RNA. Floor effects were minimal, whereas ceiling effects were pronounced for role functioning and social functioning and notable for physical functioning and pain. Internal consistency was acceptable across all multi-item domains (Cronbach\u2019s\n                      <jats:italic>\u03b1<\/jats:italic>\n                      , 0.770\u20130.924), and test\u2013retest reliability was satisfactory [ICC (2,1), 0.708\u20130.850]. A parsimonious two-factor domain-level structure was supported. Clinically, comorbidity, CD4\u202f&amp;lt;\u202f500 cells\/mm\n                      <jats:sup>3<\/jats:sup>\n                      , and a history of AIDS-defining illness were associated with poorer scores in selected domains, whereas scores did not differ by tablet burden.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The Turkish MOS-HIV showed acceptable reliability and structural validity in a young, predominantly male, virologically suppressed population in urban tertiary care, and distinguished HRQoL differences by comorbidity, CD4 status, and history of AIDS-defining illness but not by tablet burden. Evaluation in women, older PLWH and more clinically heterogeneous populations is needed before broader use.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpubh.2026.1966184","type":"journal-article","created":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T05:21:55Z","timestamp":1791264115000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Reliability and validity of the Turkish translation of the MOS-HIV health survey in people living with HIV"],"prefix":"10.3389","volume":"14","author":[{"given":"Recep","family":"Bal\u0131k","sequence":"first","affiliation":[{"name":"Haydarpa\u015fa Numune E\u011fitim ve Ara\u015ft\u0131rma Hastanesi, Infectious Diseases and Clinical Microbiology","place":["\u0130stanbul, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seniha","family":"\u015eenbayrak","sequence":"additional","affiliation":[{"name":"Haydarpa\u015fa Numune E\u011fitim ve Ara\u015ft\u0131rma Hastanesi, Infectious Diseases and Clinical Microbiology","place":["\u0130stanbul, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ercan","family":"Yenilmez","sequence":"additional","affiliation":[{"name":"Fatih Sultan Mehmet E\u011fitim ve Ara\u015ft\u0131rma Hastanesi, Infectious Diseases and Clinical Microbiology","place":["\u0130stanbul, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ay\u00e7a","family":"Ayd\u0131n","sequence":"additional","affiliation":[{"name":"GATA Haydarpa\u015fa E\u011fitim Hastanesi Infectious Diseases and Clinical Microbiology","place":["\u0130stanbul, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derya","family":"\u00d6zt\u00fcrk Engin","sequence":"additional","affiliation":[{"name":"Sancaktepe \u015eehit Prof. Dr. \u0130lhan Varank E\u011fitim ve Ara\u015ft\u0131rma Hastanesi, Infectious Diseases and Clinical Microbiology","place":["\u0130stanbul, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatma","family":"Y\u0131lmaz Karada\u011f","sequence":"additional","affiliation":[{"name":"Sancaktepe \u015eehit Prof. Dr. \u0130lhan Varank E\u011fitim ve Ara\u015ft\u0131rma Hastanesi, Infectious Diseases and Clinical Microbiology","place":["\u0130stanbul, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6zge","family":"\u00c7ayda\u015f\u0131","sequence":"additional","affiliation":[{"name":"Sancaktepe \u015eehit Prof. Dr. \u0130lhan Varank E\u011fitim ve Ara\u015ft\u0131rma Hastanesi, Infectious Diseases and Clinical Microbiology","place":["\u0130stanbul, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Semiha","family":"\u00c7elik Ekinci","sequence":"additional","affiliation":[{"name":"Fatih Sultan Mehmet E\u011fitim ve Ara\u015ft\u0131rma Hastanesi, Infectious Diseases and Clinical Microbiology","place":["\u0130stanbul, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nagehan Didem","family":"Sar\u0131","sequence":"additional","affiliation":[{"name":"\u0130stanbul E\u011fitim ve Ara\u015ft\u0131rma Hastanesi, Infectious Diseases and Clinical Microbiology","place":["\u0130stanbul, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selami","family":"Erdin\u00e7","sequence":"additional","affiliation":[{"name":"Haydarpa\u015fa Numune E\u011fitim ve Ara\u015ft\u0131rma Hastanesi, Infectious Diseases and Clinical Microbiology","place":["\u0130stanbul, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nurg\u00fcl","family":"Ceran","sequence":"additional","affiliation":[{"name":"Haydarpa\u015fa Numune E\u011fitim ve Ara\u015ft\u0131rma Hastanesi, Infectious Diseases and Clinical Microbiology","place":["\u0130stanbul, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,10,6]]},"reference":[{"key":"ref1","year":"2025"},{"key":"ref2","year":""},{"key":"ref3","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1097\/QAD.0b013e32834dcec9","article-title":"Projected life expectancy of people with HIV according to timing of diagnosis","volume":"26","author":"Nakagawa","year":"2012","journal-title":"AIDS"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"e32","DOI":"10.1016\/S2352-3018(14)70018-9","article-title":"Health-related quality-of-life of people with HIV in the era of combination antiretroviral treatment: a cross-sectional comparison with the general population","volume":"1","author":"Miners","year":"2014","journal-title":"Lancet HIV"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1177\/1545109712456429","article-title":"More than 20 years of research into the quality of life of people with HIV and AIDS\u2014A descriptive review of study characteristics and methodological approaches of published empirical studies","volume":"12","author":"Drewes","year":"2013","journal-title":"J Int Assoc Provid AIDS Care"},{"key":"ref6","first-page":"543","volume-title":"International Encyclopedia of Public Health","author":"Hays","year":"2017"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1097\/JNC.0000000000000064","article-title":"Mental and physical quality of life by age groups in persons with HIV","volume":"30","author":"Jang","year":"2019","journal-title":"J Assoc Nurses AIDS Care"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12916-016-0640-4","article-title":"Beyond viral suppression of HIV\u2013the new quality of life frontier","volume":"14","author":"Lazarus","year":"2016","journal-title":"BMC Med"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1016\/S0140-6736(19)31231-0","article-title":"UNAIDS survey aligns with so-called fourth 90 for HIV\/AIDS","volume":"393","author":"Webster","year":"2019","journal-title":"Lancet"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"e807","DOI":"10.1016\/S2352-3018(19)30379-0","article-title":"Living well with HIV","volume":"6","year":"2019","journal-title":"Lancet HIV"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"e59","DOI":"10.1016\/S2352-3018(19)30345-5","article-title":"Patient-reported outcomes to enhance person-centred HIV care","volume":"7","author":"Kall","year":"2020","journal-title":"Lancet HIV."},{"key":"ref12","year":""},{"key":"ref13","year":""},{"key":"ref14","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s12955-017-0778-6","article-title":"Measuring quality of life among people living with HIV: a systematic review of reviews","volume":"15","author":"Cooper","year":"2017","journal-title":"Health Qual Life Outcomes"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12955-021-01910-w","article-title":"Psychometric properties of self-reported measures of health-related quality of life in people living with HIV: a systematic review","volume":"20","author":"Wen","year":"2022","journal-title":"Health Qual Life Outcomes"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1023\/A:1018451930750","article-title":"Evidence for reliability, validity and usefulness of the medical outcomes study HIV health survey (MOS-HIV)","volume":"6","author":"Wu","year":"1997","journal-title":"Qual Life Res"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1097\/00005650-199108000-00011","article-title":"A health status questionnaire using 30 items from the medical outcomes study: preliminary validation in persons with early HIV infection","volume":"29","author":"Wu","year":"1991","journal-title":"Med Care"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"128","DOI":"10.2174\/011570162X284526240219075823","article-title":"Turkish translation and cross-cultural validity of WHOQOL-HIV Bref tool","volume":"22","author":"Derin","year":"2024","journal-title":"Curr HIV Res"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"e17873","DOI":"10.7717\/peerj.17873","article-title":"Validation of PozQoL scale in Turkish population living with HIV: a cross-cultural adaptation study","volume":"12","author":"Atalay","year":"2024","journal-title":"PeerJ"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1002\/hpm.3450","article-title":"Comparison of Turkish version of the medical outcomes study-HIV health survey with short form health survey-36 in people living with human immunodeficiency virus","volume":"37","author":"Tukenmez Tigen","year":"2022","journal-title":"Int J Health Plann Manag"},{"key":"ref21","year":"2018"},{"key":"ref22","year":"2026"},{"key":"ref23","volume-title":"Analysis of the Cognitive Interview In Questionnaire Design","author":"Willis","year":"2015"},{"key":"ref24","article-title":"Cognitive interviewing: think-aloud vs. verbal probing for questionnaire pretesting [Internet]","author":"CASRAI Editorial Board","year":"2026"},{"key":"ref25","volume-title":"MOS-HIV Health Survey Users Manual","author":"Wu","year":"2021"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1002\/sim.1108","article-title":"Sample size requirements for estimating intraclass correlations with desired precision","volume":"21","author":"Bonett","year":"2002","journal-title":"Stat Med"},{"key":"ref27","doi-asserted-by":"crossref","DOI":"10.1017\/CBO9780511996214","volume-title":"Measurement in Medicine: A Practical Guide","author":"de Vet","year":"2011"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1097\/00005650-199802000-00003","article-title":"Reliability and validity of physical and mental health summary scores from the medical outcomes study HIV health survey","volume":"36","author":"Revicki","year":"1998","journal-title":"Med Care"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/BF01593882","article-title":"Individual-patient monitoring in clinical practice: are available health status surveys adequate?","volume":"4","author":"McHorney","year":"1995","journal-title":"Qual Life Res"},{"key":"ref30","volume-title":"Statistical power Analysis for the Behavioral Sciences","author":"Cohen","year":"1988"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/10705519909540118","article-title":"Cutoff criteria for fit indexes in covariance structure analysis: conventional criteria versus new alternatives","volume":"6","author":"Hu","year":"1999","journal-title":"Struct Equ Model"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s12955-018-0919-6","article-title":"Psychometric properties of the Korean version of the medical outcomes study HIV health survey: results from a multicenter survey in Korea","volume":"16","author":"Shim","year":"2018","journal-title":"Health Qual Life Outcomes"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1097\/00005650-199909000-00007","article-title":"Reliability and validity of French, German, Italian, Dutch, and UK English translations of the medical outcomes study HIV health survey","volume":"37","author":"Scott-Lennox","year":"1999","journal-title":"Med Care"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.dr.2016.06.004","article-title":"Measurement invariance conventions and reporting: the state of the art and future directions for psychological research","volume":"41","author":"Putnick","year":"2016","journal-title":"Dev Rev"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1477-7525-9-15","article-title":"Reliability and validity of Thai versions of the MOS-HIV and SF-12 quality of life questionnaires in people living with HIV\/AIDS","volume":"9","author":"Chariyalertsak","year":"2011","journal-title":"Health Qual Life Outcomes"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s11136-010-9733-2","article-title":"Validation of the medical outcomes study HIV (MOS-HIV) health survey among HIV-infected patients in Taiwan","volume":"20","author":"Hsiung","year":"2011","journal-title":"Qual Life Res"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"e0201177","DOI":"10.1371\/journal.pone.0201177","article-title":"Reliability and validity of the Chinese version of the medical outcomes study HIV health survey (MOS-HIV) in people living with HIV\/AIDS (PLWHA) in China","volume":"13","author":"Liu","year":"2018","journal-title":"PLoS One"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/S0254-6272(17)30325-4","article-title":"Reliability and validity of Persian version of medical outcome study-HIV health survey in Iranian people living with HIV","volume":"37","author":"Alamolhoda","year":"2017","journal-title":"J Tradit Chin Med"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1080\/09540120903207292","article-title":"Validation of the MOS-HIV as a measure of health-related quality of life in persons living with HIV and liver disease","volume":"22","author":"Henderson","year":"2010","journal-title":"AIDS Care"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1007\/s11136-005-5914-9","article-title":"Validation of a Chinese version of the medical outcomes study HIV health survey (MOS-HIV) among Chinese people living with HIV\/AIDS in Hong Kong","volume":"15","author":"Lau","year":"2006","journal-title":"Qual Life Res"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1186\/s12913-019-4659-z","article-title":"Clinical determinants associated with quality of life for people who live with HIV\/AIDS: a meta-analysis","volume":"19","author":"Ghiasvand","year":"2019","journal-title":"BMC Health Serv Res"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"16535","DOI":"10.1038\/s41598-023-43434-x","article-title":"Factors associated with poorer quality of life in people living with HIV in southwestern France in 2018\u20132020 (ANRS CO3 AQUIVIH-NA cohort: QuAliV study)","volume":"13","author":"Barger","year":"2023","journal-title":"Sci Rep"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.2147\/PPA.S514101","article-title":"Health-related quality of life among patients living with HIV\/AIDS in Vietnam: a cross-sectional study","volume":"19","author":"Vo","year":"2025","journal-title":"Patient Prefer Adherence"},{"key":"ref44","volume-title":"Confirmatory factor Analysis for Applied Research","author":"Brown","year":"2015"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"73","DOI":"10.2147\/PROM.S239429","article-title":"Health-related quality of life among people living with human immunodeficiency virus on highly active antiretroviral therapy in Ethiopia: PROQOL-HIV based survey","volume":"11","author":"Melaku","year":"2020","journal-title":"Patient Relat Outcome Meas"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"e0262533","DOI":"10.1371\/journal.pone.0262533","article-title":"Patient-reported outcomes among people living with HIV on single- versus multi-tablet regimens: data from a real-life setting","volume":"17","author":"Degroote","year":"2022","journal-title":"PLoS One"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"115","DOI":"10.2147\/PPA.S10330","article-title":"One-pill once-a-day HAART: a simplification strategy that improves adherence and quality of life of HIV-infected subjects","volume":"4","author":"Airoldi","year":"2010","journal-title":"Patient Prefer Adherence"},{"key":"ref48","year":""}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1966184\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T05:21:57Z","timestamp":1791264117000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1966184\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,6]]},"references-count":48,"alternative-id":["10.3389\/fpubh.2026.1966184"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2026.1966184","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,6]]},"article-number":"1966184"}}